Disagree
Home Driada Medical Driada Medical
Sartanos 20
Sartanos 20 - Driada Medical

Sartanos 20 - Driada Medical

Brand:
Category:
Substance:
Dosage:
20 mg/tab
Package:
100 tablets
Price:
$34.00 - $34.00
See options
Product Overview

Known as an antihypertensive agent, telmisartan has recently gained attention for its possible antitumor properties. Studies show that telmisartan effectively slows the proliferation of esophageal squamous cell carcinoma (ESCC) cells by promoting cell-cycle arrest, a vital mechanism in cancer inhibition. By targeting proteins such as cyclin A2 and CDK2, telmisartan arrests cancer cells in the S-phase, thereby controlling cell growth. Additionally, telmisartan influences receptor tyrosine kinases, specifically ErbB3, which plays a role in cellular proliferation. The potential for telmisartan to act against cancer progression, especially in ESCC, highlights its promise beyond hypertension treatment and marks it as a candidate for targeted cancer therapies.

References:

Matsui, T., Chiyo, T., Kobara, H., Fujihara, S., Fujita, K., Namima, D., Nakahara, M., Kobayashi, N., Nishiyama, N., Yachida, T., Morishita, A., Iwama, H., and Masaki, T. (2019) Telmisartan inhibits cell proliferation and tumor growth of esophageal squamous cell carcinoma by inducing S-phase arrest in vitro and in vivo', International Journal of Molecular Sciences.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Sartanos 20 by Driada Medical, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
How does telmisartan affect cancer cell growth?
In ESCC, telmisartan has been shown to induce cell-cycle arrest in the S-phase by reducing levels of cell-cycle proteins like cyclin A2 and CDK2, slowing cancer cell proliferation.
References:

Matsui, T., Chiyo, T., Kobara, H., Fujihara, S., Fujita, K., Namima, D., Nakahara, M., Kobayashi, N., Nishiyama, N., Yachida, T., Morishita, A., Iwama, H., and Masaki, T. (2019) Telmisartan inhibits cell proliferation and tumor growth of esophageal squamous cell carcinoma by inducing S-phase arrest in vitro and in vivo', International Journal of Molecular Sciences.

Can telmisartan promote apoptosis in cancer cells?
Although telmisartan has been linked to apoptosis in some cancers, like endometrial and lung cancers, its primary effect on ESCC appears to be through cell-cycle arrest rather than apoptosis.
References:

Matsui, T., Chiyo, T., Kobara, H., Fujihara, S., Fujita, K., Namima, D., Nakahara, M., Kobayashi, N., Nishiyama, N., Yachida, T., Morishita, A., Iwama, H., and Masaki, T. (2019) Telmisartan inhibits cell proliferation and tumor growth of esophageal squamous cell carcinoma by inducing S-phase arrest in vitro and in vivo', International Journal of Molecular Sciences.

What role does telmisartan play in receptor tyrosine kinase (RTK) regulation?
Telmisartan can downregulate ErbB3, a receptor involved in cell proliferation and survival, suggesting it may disrupt cancer cell signaling pathways.
References:

Matsui, T., Chiyo, T., Kobara, H., Fujihara, S., Fujita, K., Namima, D., Nakahara, M., Kobayashi, N., Nishiyama, N., Yachida, T., Morishita, A., Iwama, H., and Masaki, T. (2019) Telmisartan inhibits cell proliferation and tumor growth of esophageal squamous cell carcinoma by inducing S-phase arrest in vitro and in vivo', International Journal of Molecular Sciences.